Medical Properties Trust, Inc. (MPW) Expected to Post Earnings of $0.34 Per Share

Wall Street brokerages expect that Medical Properties Trust, Inc. (NYSE:MPW) will post $0.34 earnings per share for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Medical Properties Trust’s earnings. The highest EPS estimate is $0.36 and the lowest is $0.33. Medical Properties Trust posted earnings of $0.33 per share during the same quarter last year, which indicates a positive year over year growth rate of 3%. The business is scheduled to report its next quarterly earnings report on Thursday, November 1st.

According to Zacks, analysts expect that Medical Properties Trust will report full-year earnings of $1.39 per share for the current fiscal year, with EPS estimates ranging from $1.36 to $1.44. For the next financial year, analysts expect that the firm will post earnings of $1.42 per share, with EPS estimates ranging from $1.35 to $1.46. Zacks’ earnings per share calculations are a mean average based on a survey of analysts that that provide coverage for Medical Properties Trust.

Medical Properties Trust (NYSE:MPW) last posted its quarterly earnings data on Thursday, August 2nd. The real estate investment trust reported $0.30 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.06). Medical Properties Trust had a net margin of 44.46% and a return on equity of 9.12%. The business had revenue of $201.90 million during the quarter, compared to the consensus estimate of $206.72 million. During the same period in the prior year, the company posted $0.32 earnings per share. The firm’s revenue was up 21.0% compared to the same quarter last year.

MPW has been the subject of a number of recent research reports. JMP Securities set a $16.00 target price on Medical Properties Trust and gave the company a “buy” rating in a research note on Monday, October 1st. Jefferies Financial Group lowered Medical Properties Trust from a “buy” rating to a “hold” rating and set a $15.00 target price for the company. in a research note on Tuesday, July 17th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $14.31.

In other Medical Properties Trust news, insider R Steven Hamner sold 35,000 shares of the stock in a transaction on Monday, August 6th. The stock was sold at an average price of $14.73, for a total transaction of $515,550.00. Following the completion of the transaction, the insider now directly owns 1,114,044 shares in the company, valued at $16,409,868.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP James Kevin Hanna sold 15,000 shares of the stock in a transaction on Friday, August 17th. The stock was sold at an average price of $14.84, for a total value of $222,600.00. The disclosure for this sale can be found here. Insiders have sold 153,409 shares of company stock valued at $2,281,467 over the last quarter. Corporate insiders own 0.83% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in MPW. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new position in Medical Properties Trust during the second quarter worth $104,000. Valeo Financial Advisors LLC acquired a new position in Medical Properties Trust during the second quarter worth $128,000. Integrated Investment Consultants LLC acquired a new position in Medical Properties Trust during the second quarter worth $136,000. Investors Asset Management of Georgia Inc. GA ADV acquired a new position in Medical Properties Trust during the second quarter worth $140,000. Finally, Signaturefd LLC raised its stake in Medical Properties Trust by 44.0% during the second quarter. Signaturefd LLC now owns 11,349 shares of the real estate investment trust’s stock worth $159,000 after acquiring an additional 3,468 shares in the last quarter. Hedge funds and other institutional investors own 77.02% of the company’s stock.

Shares of MPW traded down $0.05 during mid-day trading on Friday, hitting $14.06. The company’s stock had a trading volume of 2,577,600 shares, compared to its average volume of 2,078,485. Medical Properties Trust has a one year low of $11.82 and a one year high of $15.24. The company has a current ratio of 2.19, a quick ratio of 2.19 and a debt-to-equity ratio of 1.26. The stock has a market capitalization of $5.44 billion, a price-to-earnings ratio of 10.41, a P/E/G ratio of 3.10 and a beta of 0.55.

The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 11th. Shareholders of record on Thursday, September 13th were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Wednesday, September 12th. This represents a $1.00 annualized dividend and a yield of 7.11%. Medical Properties Trust’s dividend payout ratio is currently 74.07%.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Read More: Google Finance Portfolio Tips and Tricks

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply